MYQORZO

Serial Number 97619234
733

Registration Progress

Application Filed
Oct 4, 2022
Under Examination
Mar 21, 2023
Approved for Publication
Jan 24, 2023
Published for Opposition
Jan 24, 2023
Registered

Attorney Assistance

Important Deadline Approaching
Statement of Use Due - Extension 4 Granted
Due: September 21, 2025 76 days remaining

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
97619234
Deadline
September 21, 2025
Description
Statement of Use or 5th Extension Due
Filing Date
October 4, 2022
Published for Opposition
January 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Feb 10, 2025
Application
Pending
Classes
005

Rights Holder

Cytokinetics, Incorporated

03
Address
350 Oyster Point Blvd
South San Francisco, CA 94080

Ownership History

Cytokinetics, Incorporated

Original Applicant
03
South San Francisco, CA

Cytokinetics, Incorporated

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
B. Brett Heavner

USPTO Deadlines

Next Deadline
76 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
September 21, 2025
Extension Available
Until March 21, 2024

Application History

24 events
Date Code Type Description
Feb 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2025 EX4G S SOU EXTENSION 4 GRANTED
Feb 10, 2025 EXT4 S SOU EXTENSION 4 FILED
Feb 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 13, 2024 EX3G S SOU EXTENSION 3 GRANTED
Aug 13, 2024 EXT3 S SOU EXTENSION 3 FILED
Aug 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2024 EXT2 S SOU EXTENSION 2 FILED
Feb 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 15, 2024 EX2G S SOU EXTENSION 2 GRANTED
Sep 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 8, 2023 EX1G S SOU EXTENSION 1 GRANTED
Sep 8, 2023 EXT1 S SOU EXTENSION 1 FILED
Sep 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 21, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 24, 2023 PUBO A PUBLISHED FOR OPPOSITION
Jan 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2022 DOCK D ASSIGNED TO EXAMINER
Oct 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 7, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction

Classification

International Classes
005